POETF News Alert Poet Technologies Inc. (POETF) 1.0400 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board

Feb 15, 2015 at 9:51 AM

Poet Technologies Inc. (POETF) 1.0400 $POETF

POET Technologies Announces the Completion of the "3rd Party Foundry" 40/100-nm Transfer Milestone and Corporate Updates
Marketwired - Tue Feb 10, 7:31AM CST
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) (the "Company"

- developer of the planar opto-electronic technology ("POET"

platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced the completion of its "3rd party foundry" 40/100-nm transfer milestone. The Company also announced $4 Million in additional capital raised from institutional and accredited shareholders through the exercise of warrants during the month of January 2015, and the resignation of Dr. Adam Chowaniec from its Board.
PTK.VN: 1.280 (-0.070)

Today In SA PRO: Wednesday, January 28
SA PRO Top Ideas - Seeking Alpha - Thu Jan 29, 4:00AM CST
Top Idea : Carnival Corporation by Helix Investment Research: Long / Large-Cap / Services / GARP / Cyclical Swing / Relative Valuation / 30% Upside Outstanding Performance Award Winner #1: Top short idea on AAMC (Altisource Asset Management) ...
ORB: 28.85 (+0.21), CCL: 43.48 (-0.89)

Wall Street Breakfast: Apple Makes Quarterly Profit History
Wall Street Breakfast - at Seeking Alpha - Wed Jan 28, 5:30AM CST

ORB: 28.85 (+0.21), AXP: 78.08 (-2.40), GOOG: 549.01 (+6.08), YHOO: 44.42 (+0.50), T: 34.66 (+0.05), PBR: 6.98 (+0.44), RDS.B: 69.26 (+0.86), SPY: 209.78 (+0.86), RDS.A: 66.32 (+0.97), QQQ: 106.91 (+0.91), GOOGL: 551.16 (+5.15), AAPL: 127.08 (+0.62), MA: 87.14 (-0.38), SYK: 94.51 (+1.14), BABA: 89.05 (+1.95)

POET Technologies Announces Operational, Financial Position, "Lab-to-Fab" Transition, and Milestone Updates
Marketwired - Thu Jan 08, 7:31AM CST
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) (the "Company"

- developer of the planar opto-electronic technology ("POET"

platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced key operational, financial position, "Lab-to-Fab" transition, and milestone updates.
PTK.VN: 1.280 (-0.070)

POET Technologies Announces the Appointment of Ajit Manocha as Co-Chairman of the Board and the Search for a Permanent CEO
Marketwired - Wed Nov 19, 2:44PM CST
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) (the "Company"

- developer of the planar opto-electronic technology ("POET"

platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor chip - today announced the appointment of Mr. Ajit Manocha as Co-Chairman of the Board of Directors of the Company (the "Board"

, his appointment to the Corporate Governance and Nominating Committee with the mandate to identify a permanent Chief Executive Officer ("CEO"

for the Company, and the resignation of Dr. Samuel Peralta from the Board.
PTK.VN: 1.280 (-0.070)

POET Technologies Announces an Update on the "Lab-to-Fab" Transition and the 100-nm and 40-nm Scaling Program
Marketwired - Wed Oct 22, 7:33AM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) (the "Company"

- developer of the planar opto-electronic technology ("POET"

platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced several key updates on its "Lab-to-Fab" transition and its 100-nm and 40-nm scaling program and several operational updates.
PTK.VN: 1.280 (-0.070)

POET Technologies: Disposition of Shares by Chief Scientist
Marketwire - Thu Oct 02, 7:39AM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) ("the Company"

- developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - announces that Dr. Geoff Taylor, Chief Scientist of the Company, has disposed of 300,000 common shares of the Company on October 1, 2014.
PTK.VN: 1.280 (-0.070)

POET Announces a Collaboration with Third Party Foundry to Reproduce and Enhance Repeatability of the 100-nm Results and Shrink its Planar Electrical Technology Process (PET) to 40-nm Scale
Marketwire - Tue Sep 02, 7:04AM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) ("the Company"

- developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced an agreement with a "3rd party foundry" to reproduce and enhance repeatability of the 100-nm scale results obtained at the Company's labs (the "POET labs"

located at the University of Connecticut (UCONN). The "3rd party foundry" will also assist the POET team in shrinking the 100-nm PET devices and process to a 40-nm feature size.
PTK.VN: 1.280 (-0.070), SNPS: 44.90 (+0.03)

POET Technologies and Synopsys Collaborate on Advanced Modeling of Planar Electrical Technology and Development of POET's First Process Design Kit
Marketwire - Tue Sep 02, 6:01AM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) ("the Company"

- developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced a collaboration with Synopsys, Inc. -- a global leader providing software, IP and services used to accelerate innovation in chips and electronic systems -- to develop an advanced model and first Process Design Kit (PDK) of POET's electrical devices (PET) targeting the 40-nm technology node widely used for highly integrated systems-on-chip (SoC).
PTK.VN: 1.280 (-0.070), SNPS: 44.90 (+0.03)

POET Technologies Announces Results of Annual Meeting
Marketwire - Fri Aug 15, 4:06PM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) ("the Company"

held on August 12, 2014. The shareholders approved, with the requisite majorities, all matters presented to the meeting, including the 2014 Stock Option Plan, the By-Law No. 1 amendment, the possible Share Consolidation, the Shareholders' Rights Plan and the election of the following nominees to the Board of Directors as was proposed in the Information Circular:
PTK.VN: 1.280 (-0.070)

POET Technologies Announces Completion of a New Valuation Report
Marketwire - Wed Aug 06, 7:31AM CDT
POET Technologies Inc. (TSX VENTURE: PTK)(OTCQX: POETF) ("the Company"

- developer of the planar opto-electronic technology (POET) platform for monolithic fabrication of integrated circuit devices containing both electronic and optical elements on a single semiconductor wafer - today announced that it has received a new valuation report on its intellectual property (the "New P&A Report"

from Pellegrino and Associates LLC ("P&A"

. The New P&A Report contains a great deal of proprietary and sensitive confidential information, and will not be made public. A copy of the detailed summary (the "Summary"

of the new P&A report which has been approved by P&A will be filed on the Company's website at www.poet-technologies.com, with the Company's electronic filings on SEDAR (www.sedar.com) in Canada and on Edgar (https://www.sec.gov/edgar/searchedgar/companysearch.html) in the United States. The effective date of the opinions and conclusions in the New P&A report is March 1, 2014 and the effective date of the written report is July 22, 2014. The New P&A Report and the Summary contain several disclaimers, key assumptions, definitions, risks factors, methodologies, and limiting factors which should be reviewed carefully in the Summary for a more complete understanding of the ascribed value.
PTK.VN: 1.280 (-0.070)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

YSTUDIO's Pens: A Nod to the Power of Writing

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Kentucky Power's Bold Plan to Boost Local Economy

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

KeyCorp Plans Redemption of Series E Preferred Stock

KeyCorp Drops a Major Redemption Bombshell Out of the blue, KeyCorp (NYSE: KEY) just tossed a curveball at investors with the announcement they’re redeeming every last one of their Series E Fixed-to-Floating Rate Perpetual Non-Cumulative Preferred Stock shares come December 15, 2026. This move is bound to stir the pot a bit even if you’ve been around the block a few...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

BIBIBOP Brings Good Vibes with OLIPOP Happy Hour

Boosting Midday Energy with BIBIBOP's New Promo Here we go, folks. BIBIBOP Asian Grill is dialing up the culinary energy just when you need it most. From November 16 to 22, during their Good Energy Happy Hour, they’re serving up a deal designed to pump some pep into your afternoon—free OLIPOP prebiotic soda with any regular bowl purchase. Just stroll into any of their...

FiEE Rockets to Profitability with 382% Revenue Surge

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...